Our Cases

Compass Lexecon has been involved in many of the largest and most complex antitrust litigation and financial market cases over the past 30 years.

Find a Case

Sorry, your search didn't return any results.

01/17/23

At the beginning of November 2022, US-based consumer water services company Culligan International completed its combination with Waterlogic Holdings, a B2B provider of drinking water dispensers, after obtaining all necessary approvals from competition authorities. Compass Lexecon assisted Culligan throughout the...

09/20/22

On September 12, 2022, the $8.6B merger of NortonLifeLock (NLOK, Tempe, AZ) and Avast PLC (AVASF, Prague, Czechia) cleared merger control in all global jurisdictions following reviews from the US DOJ and the UK CMA. A Compass Lexecon team led by...

06/10/19

On 16 April 2019, the CMA approved the acquisition of Exterion Media by Global Media & Entertainment Limited (Global) at Phase I, combining two of the largest outdoor advertising companies in the UK. Compass Lexecon experts worked closely with the legal...

05/18/17

In May 2017, the European Commission approved the $7.4 billion acquisition of Baker Hughes by General Electric (GE) without remedies after a Phase I investigation. The newly formed BHGE combined the digital solutions and technology from GE with Baker Hughes'...

07/22/16

In July 2016, the European Commission ("EC") approved the transaction by which EPH, a Slovakian energy Group, acquired a controlling share in Sloveske Elektrane (“SE”) from Enel SpA for €375 million. SE is the successor to the former state monopoly...

05/22/16

Compass Lexecon advised Baker Hughes during its proposed $28 billion merger with rival oilfield services provider, Halliburton. The acquisition of Baker Hughes by Halliburton would have combined the world's number two and number three oil service companies. The parties abandoned...

12/21/14

In December 2014, the UK Competition and Markets Authority ("CMA") cleared the £700 million ($1.2 billion) acquisition by The Cooper Companies of Sauflon Pharmaceuticals, after a Phase I investigation, without remedies. The companies overlapped in the manufacturing and distribution of...